STASIS Clinical Study Begins in Europe
Top-line Data Expected by Year End
NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ – Micro Interventional Devices, Inc. (MID) reports the first successful clinical case using its Permaseal Cardiac Access and Closure technology. This new technology ... READ MORE>>
BioAdvance Biotechnology Greenhouse
of Southeastern Pennsylvania
215.966.6214 | bioadvance.com
Life Sciences Greenhouse
of Central Pennsylvania
717.635.2100 | lsgpa.com
Pittsburgh Life Sciences
Greenhouse
412.201.7370 | plsg.com
Recent Posts
READ MORE>>
Source: BioAdvance
READ MORE>>
Source: LSGPA
Is Artificial Intelligence the Next Big Thing in Biotech?
#AI has the potential to reduce the time and costs involved in developing pharmaceuticals, but proper execution is essential.
1 likes, 0 comments ⋅ 2 days ago